Richard H. Scheller, See Remarks at BridgeBio Pharma, Inc. (BBIO), sold 120,802 shares at $64.81 ($7.9M) on 2020-12-21, disclosed to the SEC on 2020-12-23.
Open-market sale of $7.9M BBIO by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.81 | 14,928 | $967K | 12.3% |
| 2 | $64.81 | 14,928 | $967K | 12.3% |
| 3 | $65.48 | 45,473 | $3.0M | 37.7% |
| 4 | $65.48 | 45,473 | $3.0M | 37.7% |
| Total | $65.31 avg | 120,802 | $7.9M | 100% |
| Filing → |
| DICE | SELL | 2023-05-09 | $6.5M | — | Filing → |
| ME | SELL | 2022-11-14 | $119K | — | Filing → |
| ALEC | SELL | 2021-08-09 | $3.7M | — | Filing → |